Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Contract Win

8 May 2013 07:00

RNS Number : 1342E
ViaLogy PLC
08 May 2013
 



ViaLogy Contracted for QuantumRD Services in Ecuador

 

London, May, 8th 2013. ViaLogy PLC (VIY) announces it has signed a contract with a subsidiary of Singapore-based Gente Oil Global, Pte. Ltd. to apply its QuantumRD seismic interpretation technology on Ecuadorian properties in the Oriente Basin. ViaLogy will focus on reservoir discovery, delineation, and development in Napo sandstone formations that have proven too complicated to understand through conventional interpretation. Project results will support the planned drilling program.

The Oriente Basin of Ecuador is a prolific producing field with nearly 3billion barrels recovered over the past 20 years. It continues to be the focus of active exploration. QuantumRD will be used to analyze 3D seismic and accurately characterize recoverable reserves from stratigraphic sandstone traps within structures associated with Andean faulting. The lithology is complex, seismically and volcanically active and, prone to rapid areal and vertical changes in geological sequence. This project leverages some of the fluid imaging capabilities developed by ViaLogy in its work for supermajors to characterize stratigraphic reservoir assets that were below the vertical resolution of vintage seismic.

Gente Oil Global is comprised of experienced industry veterans with a proven track record of working successfully with Latin American governments to develop oil and gas resources. Combined, the management team has been responsible for the discovery of billions of barrels of oil and gas equivalent.

 

ViaLogy CEO Robert Dean said, "We are pleased to be working with Gente Oil Global to support their drilling program in the Oriente Basin of Ecuador. This gives us a chance to bring some of the QuantumRD capabilities we have optimized for reservoirs in highly tectonic basins where both structural and stratigraphic elements are in play. We see Latin America as a significant potential market for QuantumRD services".

 For further information:

ViaLogy PLC

Terry Bond, Chairman - UK & Europe +44 (0) 1235 834 734

 

Cantor Fitzgerald Europe (Nominated Advisor and Broker) +44 (0) 7894 7000

Mark Percy / Catherine Leftley (Corporate Finance)

Katie Ratner (Corporate Broking)

 

About ViaLogy:

ViaLogy provides reservoir characterization, geophysical imaging and hydrocarbon sizing services to global oil and gas customers based on proprietary, patented active signal processing technology. ViaLogy's QuantumRD platform assists clients in de-risking prospects over a broad range of subsurface lithologies and complex stratigraphies to generate drilling targets, position offsets and enhance recovery.

 

ViaLogy's core technology rapidly and accurately detects weak signals buried in high noise background and clutter, and is applicable to active/passive seismic, electromagnetic and magneto telluric data. By exploiting normally disregarded noise variations induced by changes in porosity, fluid presence and permeability across the formation, and adding computer-designed noise to the data, ViaLogy is able to amplify subtle noise variations to enhance areal and depth resolution in complex lithologies that are not achievable through conventional means. For more information on ViaLogy, visit www.vialogy.com

 

About Gente Oil Global:

Gente Oil Global is a private international upstream oil and gas company focused on building an asset base across targeted regions of Latin America, North Africa, North America, and the Middle East. Chartered in Singapore in 2012 by a group of seasoned international oil and gas professionals, the company aims to capitalize on proven capabilities and contacts to create value through exploration, development and production of oil. Gente Oil Global is seeking oil exploration, production and development opportunities on the West Coast of South America such as Ecuador and Colombia, and is evaluating other opportunities globally. The primary goal of Gente Oil Global is to become a resource-rich oil producing company with multiple global assets. For more information on Gente Oil Global, visit www.genteoil.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTSSSFFWFDSEDI
Date   Source Headline
30th Nov 201511:20 amRNSNotice of Results
12th Nov 20157:00 amRNSPositive independent study results for IONA test
28th Oct 20157:00 amRNSAppointment to the Board
15th Oct 20153:56 pmRNSWorld first: in-house antenatal reflex screening
14th Oct 20157:00 amRNSClinical laboratory with expanded capacity opened
14th Oct 20157:00 amRNSHolding(s) in Company
13th Oct 20154:08 pmRNSResult of AGM
13th Oct 20152:20 pmRNSHolding(s) in Company
13th Oct 20157:01 amRNSAGM Statement
13th Oct 20157:00 amRNSPremaitha collaborates with Wolfson screening lab
12th Oct 20157:00 amRNSIndependent study of the IONA® test published
2nd Oct 20157:00 amRNSPremaitha appoints Greek distributor
1st Oct 20154:14 pmRNSPatent Infringement Proceedings Update
22nd Sep 20157:00 amRNSFinal Results
22nd Sep 20157:00 amRNSPremaitha signs contract for IONA test in Chile
15th Jul 20157:00 amRNSGrant of Options
13th Jul 20152:04 pmRNSHolding(s) in Company
6th Jul 20157:00 amRNSCQC accreditation for new NIPT lab
2nd Jul 20152:59 pmRNSCompletion of placing to raise £8 million
2nd Jul 20157:00 amRNSProposed placing to raise approximately £8 million
24th Jun 20157:00 amRNSNew IONA test clinical data showcased
22nd Jun 20157:00 amRNSNew contract for IONA® test
19th Jun 20157:00 amRNSTrading Update
4th Jun 20157:00 amRNSAppointment of Chief Financial Officer
5th May 20157:01 amRNSPremaitha Files Robust Defence with UK High Court
29th Apr 20151:53 pmRNSReissue of Options
31st Mar 20157:00 amRNSNew Contract for IONA test in Poland
23rd Mar 20159:53 amRNSLondon NHS trust teams up with Premaitha Health
16th Mar 20159:40 amRNSNotice of Patent Infringement Proceedings
16th Mar 20157:00 amRNSPremaitha Health signs first NIPT agreement
5th Feb 20157:00 amRNSCE Mark and Launch of the IONA test
30th Jan 20157:00 amRNSCommercial Launch Preparation Update
10th Dec 20147:00 amRNSResults for 7 months to 30 September 2014
25th Nov 20147:00 amRNSNotice of Half Year Results and IONA Test Showcase
4th Nov 201412:07 pmRNSResult of AGM
4th Nov 20147:00 amRNSAGM Statement
2nd Oct 20147:00 amRNSGrant of Options
30th Sep 20147:00 amRNSPublication of Annual Report and Notice of AGM
7th Jul 20144:47 pmRNSHolding(s) in Company
4th Jul 20144:28 pmRNSHolding(s) in Company
4th Jul 20147:00 amRNSFirst Day of Dealings on AIM
3rd Jul 20143:42 pmRNSChange of Name
3rd Jul 201411:36 amRNSResult of EGM
1st Jul 201410:47 amRNSOpen Offer Oversubcribed
13th Jun 20147:30 amRNSSchedule 1 - ViaLogy Plc
13th Jun 20147:30 amRNSRestoration - ViaLogy Plc
13th Jun 20147:00 amRNSPublication of Admission Document & Lifting of...
13th Jun 20147:00 amRNSDirectorate Change
13th Jun 20147:00 amRNSFinal Results
15th Apr 201412:30 pmRNSSuspension - Vialogy plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.